Everolimus therapy for progressive adrenocortical cancer.
about
MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumorsThe challenge of developmental therapeutics for adrenocortical carcinomaA phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.Adrenocortical carcinoma: the management of metastatic disease.Current management options for recurrent adrenocortical carcinoma.Genetics and epigenetics of adrenocortical tumors.Roles of the pathologist in evaluating surrogate markers for medical therapy in adrenocortical carcinoma.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Diagnosis, treatment and outcome of adrenocortical cancer.Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the LiteratureThe tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.
P2860
Q27027738-09D42994-7ADA-4E91-871C-B77D3DA1FE8AQ28072970-55B51FE8-5367-49DE-AEAB-822C337FB86DQ34017912-2C251232-869D-4852-A997-3267C7E101A3Q36081865-14515BFA-7145-4E3D-A2A2-D866BD7FF30CQ36925876-178B66D2-3EC6-40D1-BFD2-9EFC9C0AC133Q38162079-EDCBFF66-917D-4C02-AF23-9DA6FE390C06Q38253996-5C2AB37D-D5AB-4239-AA80-FCC5BFF813F2Q38258284-CB4C4466-1ABD-4639-AE1E-788D2FFD54F1Q38358503-3A94D5E9-493A-497C-A885-221424D91EFAQ38713191-48924D32-8926-4BF1-A589-FE4E7D7D437CQ38860968-7A30D57B-4CD1-4ADD-9D3A-0A1A8D1FB2CBQ41863971-6A408AC5-6CE1-4202-96E7-FD55BF856462Q52673059-6C8CE82A-5429-4A43-B7ED-5326C9EF69B6Q53251508-7E3BC135-E427-4EA1-AC59-4B4B7B996FCD
P2860
Everolimus therapy for progressive adrenocortical cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Everolimus therapy for progressive adrenocortical cancer.
@en
Everolimus therapy for progressive adrenocortical cancer.
@nl
type
label
Everolimus therapy for progressive adrenocortical cancer.
@en
Everolimus therapy for progressive adrenocortical cancer.
@nl
prefLabel
Everolimus therapy for progressive adrenocortical cancer.
@en
Everolimus therapy for progressive adrenocortical cancer.
@nl
P2093
P2860
P1433
P1476
Everolimus therapy for progressive adrenocortical cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12020-013-9878-1
P577
2013-02-16T00:00:00Z
P6179
1041176115